TISSIUM
Created in 2013
Up & running (A)
Existing signals show a regular activitySocial networks
683 11,514Global tags
Activities
Technologies
Entity types
Location
74 Rue du Faubourg Saint-Antoine, 75012 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 129
SIREN
793166299Engaged catalyst
18
0 0Added in Motherbase
4 years, 2 months ago
Value proposition
Biomorphic Programmable Polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Medical Device, MedTech, Synthetic Polymers, Tissue Reconstruction, and InnovationOriginal language
Biomorphic Programmable Polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Tissue Reconstruction Solutions | TISSIUM Biomorphic Programmable Polymers
TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
https://tissium.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 10 Oct 2022 | | |
 ZEBOX Startup accelerator & VC, Venture Capital and Private Equity Principals | ZEBOX Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 8 May 2023 | | |
 SUEZ Energy, Environment, Environmental Services | SUEZ Energy, Environment, Environmental Services | Other 22 Oct 2019 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Capitalistic Partnership Not event 31 Aug 2021 25 May 2024 | | |
 EU-Startups Media, Software Development | EU-Startups Media, Software Development | Capitalistic Not partnership Not event 31 Aug 2021 | | |
 Omnes Startup accelerator & VC, Financial Services | Omnes Startup accelerator & VC, Financial Services | Other 20 Nov 2019 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Not capitalistic Partnership Not event 26 Nov 2024 | | |
 Le Figaro Media, Newspaper Publishing | Le Figaro Media, Newspaper Publishing | Not capitalistic Not partnership Event 5 Dec 2021 | | |